RGLS4326

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
67	多発性嚢胞腎	1

67. 多発性嚢胞腎

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04536688 (ClinicalTrials.gov)	October 13, 2020	24/8/2020	A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease	A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pha ...	Polycystic Kidney Disease, Autosomal Dominant	Drug: RGLS4326	Regulus Therapeutics Inc.	NULL	Completed	18 Years	70 Years	All	19	Phase 1	United States

First Previous1Next Last